VR Logo

Kopran Ltd.


Healthcare | Drugs & Pharma

we think vacations are for wimps

40 Stocks to buy right now

Join Value Research Stock Advisor now and be among the first to discover Stock Ideas

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

ajax-loader
Please wait...

About The Company

Business: Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids;

Incorporated: 1958

Chairman: --

Managing Director: --

Group: Parijat

Listing: NSE: KOPRAN, BSE: 524280

Headquarters: Mumbai, Maharashtra

Website: www.kopran.com

Key Facts

Market cap: R 125.87 Cr

Revenue (TTM): R 371.84 Cr

Earnings (TTM): R 23.89 Cr

Cash: R 3.96 Cr

Total Debt: R 96.93 Cr

Promoters' ownership: 43.78%

Liquidity: High

52 Week range: R 15.10 - 39.95

Face value: R10.00

Shares outstanding: 4,32,52,602

10 Years Aggregate:

  • CFO: 215.92 Cr
  • EBITDA: 304.25 Cr
  • Net Profit: 81.09 Cr

Stock Performance

Time Period Kopran S&P BSE Healthcare S&P BSE Small Cap
YTD-6.5920.33-13.46
1 month7.596.8711.32
3 months9.2114.23-12.77
1 Year-26.0521.43-20.39
3 Years-30.375.22-8.36
5 Years-9.900.311.78
10 Years-1.1811.353.21
As on 05-Jun-2020
Year Kopran S&P BSE Small Cap S&P BSE Healthcare
2019-19.85-6.85-3.55
2018-42.51-23.41-5.89
201729.6959.640.49
2016-30.721.77-12.88
201539.306.7615.06
2014151.4769.2447.43
2013-6.57-11.2322.55